Cargando…

Correction for: Calycosin stimulates the proliferation of endothelial cells, but not breast cancer cells, via a feedback loop involving RP11-65M17.3, BRIP1 and ERα

Detalles Bibliográficos
Autores principales:	Wang, Yong, Xie, Wei, Hou, Mengyue, Tian, Jing, Zhang, Xing, Ren, Qianyao, Huang, Yue, Chen, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8954955/ https://www.ncbi.nlm.nih.gov/pubmed/35288485 http://dx.doi.org/10.18632/aging.203953

Ejemplares similares

Calycosin stimulates the proliferation of endothelial cells, but not breast cancer cells, via a feedback loop involving RP11-65M17.3, BRIP1 and ERα
por: Wang, Yong, et al.
Publicado: (2021)

Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling
por: Tian, Jing, et al.
Publicado: (2017)

Correction to: Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling
por: Tian, Jing, et al.
Publicado: (2017)

Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families
por: Ray, A M, et al.
Publicado: (2009)

Calycosin induces apoptosis in osteosarcoma cell line via ERβ-mediated PI3K/Akt signaling pathways
por: Tian, Wei, et al.
Publicado: (2020)

CRISPY-BRED and CRISPY-BRIP: efficient bacteriophage engineering
por: Wetzel, Katherine S., et al.
Publicado: (2021)

S17.3 PK/PD in the treatment of hospital-acquired pneumonia
Publicado: (2005)

Profiling of Hepatocellular Carcinoma Cell Cycle Regulating Genes Targeted by Calycosin
por: Zhang, Dongqing, et al.
Publicado: (2013)

Pharmacological targets and mechanisms of calycosin against meningitis
por: Nong, Yuan, et al.
Publicado: (2020)

A Positive Feedback Loop of ER-α36/EGFR Promotes Malignant Growth of ER-negative Breast Cancer Cells
por: Zhang, XianTian, et al.
Publicado: (2010)

Investigation of Effects and Mechanisms of Total Flavonoids of Astragalus and Calycosin on Human Erythroleukemia Cells
por: Zhang, Dongqing, et al.
Publicado: (2012)

Calycosin Influences the Metabolism of Five Probe Drugs in Rats
por: Wu, Mei-ling, et al.
Publicado: (2020)

Calycosin prevents bone loss induced by hindlimb unloading
por: Jin, Xiang, et al.
Publicado: (2022)

Urgent Repair of a 17.3 cm Inflammatory Abdominal Aortic Aneurysm
por: Mangan, Simone H, et al.
Publicado: (2021)

Olaparib Monotherapy for BRIP1-Mutated High-Grade Serous Endometrial Cancer
por: Nakamura, Kohei, et al.
Publicado: (2020)

Nuclear modification at $\sqrt{s_{NN}}=17.3$ GeV, measured at NA49
por: Laszlo, Andras
Publicado: (2008)

Identification of long noncoding RNA RP11-89K21.1 and RP11-357H14.17 as prognostic signature of endometrial carcinoma via integrated bioinformatics analysis
por: Gao, Lingling, et al.
Publicado: (2020)

Super-enhancer-controlled positive feedback loop BRD4/ERα–RET–ERα promotes ERα-positive breast cancer
por: Zheng, Zao-zao, et al.
Publicado: (2022)

The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer
por: Liu, Shu-Shu, et al.
Publicado: (2020)

Calycosin Suppresses Breast Cancer Cell Growth via ERβ-Dependent Regulation of IGF-1R, p38 MAPK and PI3K/Akt Pathways
por: Chen, Jian, et al.
Publicado: (2014)

Tagging Single Nucleotide Polymorphisms in the BRIP1 Gene and Susceptibility to Breast and Ovarian Cancer
por: Song, Honglin, et al.
Publicado: (2007)

Landscape of BRIP1 molecular lesions in gastrointestinal cancers from published genomic studies
por: Voutsadakis, Ioannis A
Publicado: (2020)

Two tSNPs in BRIP1 are associated with breast cancer during TDT analysis
por: Li, Xuefei, et al.
Publicado: (2021)

Hereditary Cancer Syndrome in a Family with Double Mutation in BRIP1 and MUTYH Genes
por: D’Elia, Giovanna, et al.
Publicado: (2023)

Novel role of BRCA1 interacting C‐terminal helicase 1 (BRIP1) in breast tumour cell invasion
por: Rizeq, Balsam, et al.
Publicado: (2020)

Contents of Volumes 166 to 173
Publicado: (2019)

Health Tract, No. 173: Insanity
Publicado: (1863)

Health Tract, No. 173: Insanity
Publicado: (1865)

Calycosin attenuates dextran sulfate sodium (DSS)-induced experimental colitis
por: Chao, Liu, et al.
Publicado: (2017)

The Role of TRPC6 in the Neuroprotection of Calycosin Against Cerebral Ischemic Injury
por: Guo, Chao, et al.
Publicado: (2017)

Pharmaceutical Values of Calycosin: One Type of Flavonoid Isolated from Astragalus
por: Gong, Guowei, et al.
Publicado: (2021)

Research on the interaction of astragaloside IV and calycosin in Astragalus membranaceus with HMGB1
por: Ye, Junyi, et al.
Publicado: (2023)

System size dependence of strange particle yields and spectra at $\sqrt{s}$=17.3 GeV
por: Kraus, Ingrid
Publicado: (2004)

Spindle Cell Hemangioma and Atypically Localized Juxtaglomerular Cell Tumor in a Patient with Hereditary BRIP1 Mutation: A Case Report
por: Papez, Jan, et al.
Publicado: (2021)

Inhibitory effect of calycosin on breast cancer cell progression through downregulating lncRNA HOTAIR and downstream targets: HuR and IGF2BP1: Calycosin inhibits breast cancer growth by regulating HOTAIR
por: Li, Yuhong, et al.
Publicado: (2022)

USP15 inhibits multiple myeloma cell apoptosis through activating a feedback loop with the transcription factor NF-κBp65
por: Zhou, Lili, et al.
Publicado: (2018)

FOXO3a Mediates Homologous Recombination Repair (HRR) via Transcriptional Activation of MRE11, BRCA1, BRIP1, and RAD50
por: Inci, Gozde, et al.
Publicado: (2022)

A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer
por: Kote-Jarai, Z, et al.
Publicado: (2009)

Loss of the BRCA1-Interacting Helicase BRIP1 Results in Abnormal Mammary Acinar Morphogenesis
por: Daino, Kazuhiro, et al.
Publicado: (2013)

BRIP1 inhibits the tumorigenic properties of cervical cancer by regulating RhoA GTPase activity
por: ZOU, WEI, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rdsfqe9kq8ab45co4pkko1k62n